02952nam 2200565 450 991046574620332120200520144314.00-19-049842-00-19-049841-2(CKB)3710000000737908(EBL)4545363(SSID)ssj0001675236(PQKBManifestationID)16484130(PQKBTitleCode)TC0001675236(PQKBWorkID)15022298(PQKB)11019846(MiAaPQ)EBC4545363(StDuBDS)EDZ0001518733(Au-PeEL)EBL4545363(CaPaEBR)ebr11237325(OCoLC)953456369(EXLCZ)99371000000073790820160810h20162016 uy 0engur|n|---|||||txtccrNeurology board review questions and answers /by Amy McGregorNew York, New York :Oxford University Press,2016.©20161 online resource (273 p.)Description based upon print version of record.0-19-989562-7 Includes bibliographical references and index.Cover; Neurology Board Review; Copyright; Dedication; Contents; 1.AUTONOMIC NERVOUS SYSTEM; 2.BEHAVIORAL NEUROLOGY; 3.CEREBROVASCULAR DISEASE; 4.CONGENITAL DISORDERS INCLUDINGNEUROCUTANEOUS DISORDERS; 5.CRITICAL CARE AND TRAUMA; 6.DEMENTIA; 7.DEMYELINATING DISEASESAND NEUROIMMUNOLOGY; 8.EPILEPSY; 9.METABOLIC DISORDERS; 10.MOVEMENT DISORDERS; 11.NEUROANATOMY; 12.NEUROCHEMISTRY; 13.NEUROGENETICS; 14.NEUROINFECTIOUS DISEASES; 15.NEUROLOGIC COMPLICATIONSOF SYSTEMIC DISEASES; 16.NEUROMUSCULAR DISEASES; 17.NEURO- ONCOLOGY; 18.NEURO- OPHTHALMOLOGY; 19.NEURO- OTOLOGY; 20.NEUROPATHOLOGY21.NEUROPHARMACOLOGY22.NEUROPHYSIOLOGY; 23.NEUROTOXICOLOGY; 24.PAIN AND HEADACHE; 25.PEDIATRIC NEUROLOGY; 26.PSYCHIATRY; 27.SLEEP DISORDERS; 28.SUBSTANCE- RELATED DISORDERS; 29.VITAMIN DEFICIENCY AND EXCESS; INDEXThis is an easy to read question and answer book that was created to prepare the reader for the American Board of Psychiatry and Neurology (ABPN) certification and recertification exams. It was specifically designed to cover the topics listed in the ABPN content outline including basic neuroscience, behavioral neurology, psychiatry, and clinical neurology. It includes questions about recent practice parameters published by the American Academy of Neurology. This book utilizes a multitude of question formating, including case-based and multiple choice questions.NeurologyExaminations, questions, etcElectronic books.Neurology616.80076McGregor Amy894393MiAaPQMiAaPQMiAaPQBOOK9910465746203321Neurology board review1998116UNINA04387nam 2200661 450 991082378450332120230614221656.00-309-31725-80-309-31723-1(CKB)3710000000465917(EBL)3439864(SSID)ssj0001600915(PQKBManifestationID)16308107(PQKBTitleCode)TC0001600915(PQKBWorkID)14893615(PQKB)11039149(MiAaPQ)EBC3439864(Au-PeEL)EBL3439864(CaPaEBR)ebr11091773(OCoLC)915981814(EXLCZ)99371000000046591720150904h20152015 uy| 0engurcnu||||||||txtccrAssessing the use of agent-based models for tobacco regulation /Committee on Assessment of Agent-Based Models to Inform Tobacco Product Regulation, Board on Population Health and Public Health Practice, Robert Wallace, Amy Geller, and V. Ayano Ogawa, Editors, Institute of Medicine of the National AcademiesWashington, District of Columbia :The National Academies Press,[2015]©20151 online resource (280 p.)Description based upon print version of record.0-309-31722-3 Includes bibliographical references and index.Front Matter; Reviewers; Contents; Acronyms and Abbreviations; Preface; Summary; 1 Introduction; 2 Tobacco Control Landscape; 3 Building Effective Models to Guide Policy Decision Making; 4 An Evaluation Framework for Policy-Relevant Agent-Based Models; 5 Review of the Social Network Analysis for Policy on Directed Graph Networks Model; 6 Data and Implementation Needs for Computational Modeling for Tobacco Control; Appendix A: Considerations and Best Practices in Agent-Based Modeling to Inform Policy--Ross A. Hammond; Appendix B: Agent-Based Models for Policy Analysis--Lawrence BlumeAppendix C: Assessing Agent-Based Models for Regulatory Applications: Lessons from Energy Analysis--Alan H. Sanstad Appendix D: Committee Meeting Agendas; Appendix E: Committee Biographical Sketches; Index"Tobacco consumption continues to be the leading cause of preventable disease and death in the United States. The Food and Drug Administration (FDA) regulates the manufacture, distribution, and marketing of tobacco products - specifically cigarettes, cigarette tobacco, roll-your-own tobacco, and smokeless tobacco - to protect public health and reduce tobacco use in the United States. Given the strong social component inherent to tobacco use onset, cessation, and relapse, and given the heterogeneity of those social interactions, agent-based models have the potential to be an essential tool in assessing the effects of policies to control tobacco. Assessing the Use of Agent-Based Models for Tobacco Regulation describes the complex tobacco environment; discusses the usefulness of agent-based models to inform tobacco policy and regulation; presents an evaluation framework for policy-relevant agent-based models; examines the role and type of data needed to develop agent-based models for tobacco regulation; provides an assessment of the agent-based model developed for FDA; and offers strategies for using agent-based models to inform decision making in the future."--Publisher's description.SmokingHealth aspectsSmoking cessationTobacco usePreventionTobacco useHealth aspectsResearchUnited StatesSmokingHealth aspects.Smoking cessation.Tobacco usePrevention.Tobacco useHealth aspectsResearch362.2960973Wallace RobertGeller Amy(Amy B.),Ogawa V. AyanoInstitute of Medicine (U.S.).Committee on Assessment of Agent-Based Models to Inform Tobacco Product Regulation,Institute of Medicine (U.S.).Board on Population Health and Public Health Practice,MiAaPQMiAaPQMiAaPQBOOK9910823784503321Assessing the use of agent-based models for tobacco regulation3929701UNINA